Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precipitation-Based Encapsulation of Fibrinogen in Calcium Carbonate for Non-Compressible Hemorrhage Control.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

SORTing out gene editing therapies for neuromuscular disorders.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Plasmin-mediated fibrinolysis is required for hematopoietic recovery after 5-FU-induced myeloablation.

Blood advances·2026
Same author

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same author

Anti-fibrinolytic strategies improve liver regeneration in mice and reduce post-hepatectomy liver failure in patients.

Blood·2026
Same author

No TFPI? APC to the rescue!

Blood·2026

Related Experiment Video

Updated: Dec 14, 2025

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

18.9K

Bleeding is increased in amyloid precursor protein knockout mouse.

Nima Mazinani1,2,3, Amy W Strilchuk1,2,3, James R Baylis1,4

  • 1Michael Smith Laboratories University of British Columbia Vancouver BC Canada.

Research and Practice in Thrombosis and Haemostasis
|July 21, 2020
PubMed
Summary
This summary is machine-generated.

Amyloid precursor protein (APP) absence increases bleeding in mice, suggesting a role in hemostasis. Platelet-derived APP and amyloid beta (Aβ) peptides are crucial for effective blood clotting.

Keywords:
blood coagulationcerebral amyloid angiopathyfibrinolysishemorrhageneurodegenerative diseasesthrombosis

More Related Videos

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse
08:08

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse

Published on: November 10, 2008

103.8K
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.8K

Related Experiment Videos

Last Updated: Dec 14, 2025

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

18.9K
A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse
08:08

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse

Published on: November 10, 2008

103.8K
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.8K

Area of Science:

  • Hematology
  • Neuroscience
  • Molecular Biology

Background:

  • Amyloid precursor protein (APP) is abundant in platelets and is a precursor to amyloid beta (Aβ).
  • APP and its metabolites exhibit complex interactions with the coagulation system, possessing both anticoagulant and procoagulant properties.
  • The specific in vivo contribution of APP to hemostasis remains largely undetermined.

Purpose of the Study:

  • To investigate the role of APP in hemostasis in a mouse model.
  • To assess the impact of APP deficiency on bleeding under various pharmacological challenges, including coagulation inhibitors.

Main Methods:

  • Comparative analysis of blood loss in APP knockout (KO) and wild-type (WT) mice using liver laceration and tail transection models.
  • Evaluation of bleeding in response to tail transection following administration of coagulation inhibitors (apixaban), antiplatelet agents (aspirin + clopidogrel), t-PA, or tranexamic acid (TXA).
  • Thromboelastography analysis of blood from APP KO and WT mice to assess clotting dynamics and clot stability.

Main Results:

  • APP KO mice exhibited increased blood loss in tail transection models compared to WT mice, while liver laceration bleeding was comparable.
  • The bleeding difference between APP KO and WT mice was abolished by combined aspirin and clopidogrel treatment.
  • Persistent bleeding differences were observed in APP KO versus WT mice treated with apixaban, t-PA, or TXA.
  • Thromboelastography revealed prolonged clotting times, reduced clot stiffness, and increased susceptibility to fibrinolysis in blood from APP KO mice.

Conclusions:

  • The absence of APP significantly exacerbates bleeding in mice, particularly under specific conditions.
  • Platelet-derived APP and its metabolites play a measurable role in promoting effective hemostasis.
  • These findings highlight a novel function of APP in the regulation of blood clotting.